MoonLake Immunotherapeutics
MLTX
#3470
Rank
A$4.93 B
Marketcap
$78.30
Share price
2.61%
Change (1 day)
20.45%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -A$0.12 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$82.9 Million, an increase over its 2022 earnings that were of -A$99.66 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.12 Billion42.77%
2023 -A$82.9 Million-16.81%
2022 -A$99.66 Million